Actively Recruiting
Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function
Led by University of Minnesota · Updated on 2025-05-08
80
Participants Needed
1
Research Sites
281 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a longitudinal study to determine the influence of the menopause transition on autonomic and vascular function. PI Keller-Ross has published data demonstrating that postmenopausal females have greater sympathetic neural reactivity during a stressor compared with age-matched males and younger females and males. A paucity of literature exists, however, on the role of the menopause transition in autonomic function because the majority of experimental studies on menopause physiology are cross-sectional and/or focused on older, postmenopausal females . The influence of age on HTN is robust, whereas the effects of menopause are still unclear. Preliminary data demonstrate a clear association between age and sympathetic activity in females; how the transition through menopause influences these relations, however, remains unknown. The study will enroll 80 midlife (45-55 years of age) females to measure longitudinally the trajectory of autonomic and vascular function during the transition through menopause. The study hypothesizes that through the menopause transition, an increase in sympathetic activity and an impaired baroreflex sensitivity and endothelial function will emerge.
CONDITIONS
Official Title
Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- Age 45 to 55 years
- Premenopausal
- Not using medications that affect autonomic function
- Having regular menstrual cycles (eumenorrheic)
- Not planning to become pregnant during the study
- English-speaking, literate, and able to provide informed consent
You will not qualify if you...
- Diabetes
- Pregnant or breastfeeding
- Cardiac or pulmonary disorders
- Severe obesity (BMI 40 kg/m2 or higher)
- Hypertension
- Obstructive sleep apnea
- Current use of heart or blood pressure medications
- Current use of hormonal contraceptives or other exogenous sex hormones
- Nicotine or tobacco use in the last six months
- Current alcohol abuse
- History of chemotherapy or radiation treatment
- Coagulopathy disorders or use of anticoagulant medications
- Current use of anxiolytics or antidepressants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneapolis, Minnesota, United States, 55414
Actively Recruiting
Research Team
E
Emma Lee, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here